Compare Adaptive Biotechnologies Corp (ADPT) vs Tractor Supply Co (TSCO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Tractor Supply Co — how do they compare? Adaptive Biotechnologies Corp trades at $19.94 (market cap $3.33B), while Tractor Supply Co trades at $29.53 (market cap $15.96B). The key difference: Tractor Supply Co is far larger — about 4.8× Adaptive Biotechnologies Corp's market cap, and Tractor Supply Co pays a 3.15% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | TSCO | |
|---|---|---|
Market Cap | $3.33B | $15.96B |
Sector | Health | Consumer Cyclical |
52-Week High | $22.37 | $62.65 |
52-Week Low | $10.24 | $29.14 |
Enterprise Value | $3.19B | $22.14B |
Dividend Yield | — | 3.15% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADPT trades at $20.82, down 1.75% today, with a bullish technical signal from moving averages and a consensus analyst price target of $20.40. The company announced a strategic separation of its MRD and Immune Medicine businesses in June 2026, alongside a $300 million convertible notes offering to enhance financial flexibility. Revenue grew to $277 million in 2025, though net losses persist at -$59.50 million, with improving margins and cash flow trends showing net positive cash generation of $22.37 million.
Outlook remains cautiously optimistic as the business split aims to unlock value, but execution risks and sustained profitability challenges pose headwinds. Analysts are predominantly bullish (64.71% buy ratings), citing growth in the clonoSEQ MRD segment, yet the stock faces volatility from high valuation multiples and insider selling activity.
TSCO trades at $30.43, down 4.19% with bearish technical signals. The stock shows mixed fundamentals with revenue growth to $15.52B in 2025 but recent earnings misses. Analyst consensus remains positive with a $44.31 price target. Recent news highlights upcoming Q2 earnings and rural market initiatives.
The outlook balances strong profitability (45.5% ROE) against consumer pressure risks. Upside exists if Q2 earnings beat expectations, but cautious rural spending and margin compression pose near-term headwinds. Valuation at 14.89 P/E offers potential if growth reaccelerates.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Tractor Supply Co
Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. Currently, the company operates 2,016 of its namesake banners in 49 states and 178 Petsense stores. Stores are typically located in towns outside of urban areas and in rural communities. In fiscal 2021, revenue consisted primarily of livestock and pet (47%), hardware, tools, and truck (21%), and seasonal gift and toy (21%).
Read more on TSCO →
